SPOTLIGHT -
Doctors are Meant to Prescribe, Not to Promote
While GlaxoSmithKline recently decided to stop paying doctors to advocate its drugs, it's possible that drug groups could be tempted to reproduce those murky practices in vulnerable emerging markets.